Helen Routh
Dr Helen Routh is a Non-Executive Director of Ultromics, bringing extensive experience as a global healthcare executive across research, innovation, business, and outcomes-based healthcare.
Helen is a board director and advisor with deep experience supporting healthcare organisations, clinical teams, and companies working to improve outcomes for patients and health systems.
Alongside her role at Ultromics, Helen is a Non-Executive Director and member of the Audit Committee for Agfa Gevaert N.V., a Non-Executive Director of Health Innovation Manchester, and a member of the Medical Advisory Board of Buoy Health.
Until 2017, Helen held a range of senior business and functional roles at Philips, including responsibility for Philips Research North America, global leadership of the Clinical Informatics businesses, and leadership of the Innovation Strategy and Integrated Solutions teams across Royal Philips' health and wellbeing portfolio.
Helen trained as a physicist and holds a PhD in medical ultrasound from the University of Wales. She is based in Boston and works with health systems, clinical organisations, and companies on both sides of the Atlantic.
Curious about upcoming research and innovation?
Sign-up to hear about the latest news.